Pembrolizumab plus chemotherapy oesophageal cancer patient case studies in adenocarcinoma

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

1. Pembrolizumab plus chemotherapy patient case study with Dr Martin Eatock

2. Pembrolizumab plus chemotherapy patient case study with Lillian Cortez

3. Pembrolizumab plus chemotherapy patient case study 2 with Lillian Cortez

These recordings involve Dr Martin Eatock, a Consultant Medical Oncologist for the Belfast Health and Social Care Trust, and Lillian Cortez, a GI Cancer Specialist Pharmacist at the Royal Marsden NHS Foundation Trust discussing Oesophageal KEYTRUDA® (pembrolizumab) plus chemotherapy patient case studies.

More information about KEYTRUDA® (pembrolizumab) in locally advanced unresectable or metastatic oesophageal cancer

Visit product page

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website